Skip to product information
1 of 2

Invivo anti-mouse PD-L1 Recombinant mAb (D265A)

Invivo anti-mouse PD-L1 Recombinant mAb (D265A)

Catalog Number: S0B0593 Application: Functional/Block/Neutralize Reactivity: Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $120.00 USD
Regular price Sale price $120.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen PD-L1
Synonyms Programmed cell death 1 ligand 1, CD274, B7-H1
Location Membrane
Accession Q9EP73
Clone Number 10F.9G2
Antibody Type Recombinant mAb
Isotype Mouse IgG1 D265A, κ
Isotype Control Invivo mouse IgG1 isotype control (D265A)
Application in vivo PD-L1 blockade
Reactivity Ms
Purification Protein G
Concentration Lot specific* (generally 10 to 20 mg/ml)*
Endotoxin <1EU/mg
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, containing no preservative

Stability & Storage

2 to 8 °C for 2 weeks under sterile conditions;

-20 °C for 3 months under sterile conditions; 

-80 °C for 24 months under sterile conditions.

Please avoid repeated freeze-thaw cycles.

Background

This antibody recognizes the same epitope as clone 10F.9G2. Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene. Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the adaptive arm of immune systems during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. The binding of PD-L1 to the inhibitory checkpoint molecule PD-1 transmits an inhibitory signal based on interaction with phosphatases (SHP-1 or SHP-2) via Immunoreceptor Tyrosine-Based Switch Motif (ITSM). This reduces the proliferation of antigen-specific T-cells in lymph nodes, while simultaneously reducing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells) - further mediated by a lower regulation of the gene Bcl-2. Upregulation of PD-L1 on immune cells (especially myeloid cells) can also lead to formation of an immunosuppressive environment in a highly localized manner that also allow the cancer cells to proliferate.

Picture

Validation Data

Anti-His antibody Immobilized on CM5 Chip captured PD-L1 His Tag, Mouse, can bind PD-L1 Recombinant Mouse mAb (10F.9G2) with an affinity constant of 0.03 nM as determined in SPR assay.

Anti-tumor efficacy of S0B0593

Anti-tumor efficacy of S0B0593

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)